WSJ Reports Merck (MRK) is Taking Steps to Aggressively Price Zocor Below Teva Pharma's (TEVA) Generic Version
Tweet Send to a Friend
WSJ reports Merck (NYSE: MRK) is taking steps to aggressively price Zocor and has negotiated reduced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


